Srinivas Rao - 13 Aug 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Co-Founder and Chief Executive Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
13 Aug 2025
Transactions value $
$0
Form type
4
Filing time
15 Aug 2025, 17:30:39 UTC
Previous filing
24 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rao Srinivas Co-Founder and Chief Executive Officer C/O ATAI LIFE SCIENCES N.V., PROF. J.H. BAVINCKLAAN 7, AMSTERDAM, NETHERLANDS /s/ Ryan Barrett, Attorney-in-fact 15 Aug 2025 0001860902

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +651K $0.00 651K 13 Aug 2025 Common Shares 651K $5.68 Direct F1
transaction ATAI Stock Option Award $0 +218K $0.00 218K 13 Aug 2025 Common Shares 218K $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No new stock options have been awarded. The transactions reported herein reflect vesting of performance-based stock options ("Performance Options") previously awarded to the Reporting Person on January 20, 2021, vesting subject to performance conditions that were subsequently satisfied, as certified and approved by the board of directors of atai Life Sciences NV as of August 13, 2025. The portion of the Performance Options is fully vested and currently exercisable with respect to the shares reported herein.

Remarks:

Co-Founder and Chief Executive Officer